Aphria and Tilray will host special shareholder meetings next month on the proposed merger between the cannabis producers, the companies said. The meetings will be held via live audio webcast for Aphria and Tilray shareholders on April 14 and April 16,…
Tilray
Canada extends wage subsidy popular with cannabis producers
Canada’s government is extending a pandemic-related wage subsidy program that has been tapped by over a dozen federally-regulated cannabis producers. The Canada Emergency Wage Subsidy (CEWS) program, which subsidizes wages for employers which hav…
Aphria-Tilray cannabis merger talks overcame pandemic pause, rival bidder and other hurdles, proxy reveals
On-again, off-again merger talks between rival cannabis producers Tilray and Aphria had their genesis in October 2019 when an unidentified investment bank active in the marijuana space pitched a meeting between the company’s respective CEOs, acco…
Canadian marijuana producer Tilray reports $271 million loss for year
Cannabis producer Tilray cut its annual loss to $271 million for 2020, an improvement from the Nanaimo, British Columbia company’s $321 million loss in 2019, according to the full-year and fourth-quarter results released Wednesday. Tilray, which is on …
Wall Street Disruptors Fuel Cannabis Investor Flameout
Wall Street Disruptors Fuel Cannabis Investor Flameout
It seems like the cannabis industry just has not found its mojo.
The post Wall Street Disruptors Fuel Cannabis Investor Flameout appeared first on The Fresh Toast.
Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis pro…
Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis pro…
Canada’s ‘croptober’ surge pushes cannabis inventory over 1 million kilograms
Canadian licensed producers added a record 220,461 kilograms of marijuana to their inventories in October 2020, according to new data offering a statistical glimpse of the country’s first large-scale “croptober” – when most of the fall outd…
Aphria grows Q2 revenue, reports CA$120.6M net loss
Canadian cannabis company Aphria reported increased quarterly revenue on Thursday for the quarter ended Nov. 30, with a net loss of 120.6 million Canadian dollars ($95.3 million). The Ontario-based firm posted net revenue of CA$160.5 million, a 10% inc…
Investment Analysts: What Democratic Senate Means For Federal Marijuana Legalization
Investment Analysts: What Democratic Senate Means For Federal Marijuana Legalization
Leading investment analysts predict that cannabis stocks will soar big time following last week’s Democratic takeover of the U.S. Senate.
The post Investment Analysts:…